NINTEDANIB vs OFEV

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. NINTEDANIB and OFEV are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	NINTEDANIB	OFEV
Rating	New	72/100
Pharmacy pays	—	~$485.32 /30
Type	RX	RX
Active ingredient	NINTEDANIB	NINTEDANIB ESYLATE
Manufacturer	Teva Pharmaceuticals Development Inc	Boehringer Ingelheim
Dosage forms	Capsule	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis

nintedanib ofev

Rating

New

72/100

Pharmacy pays

—

~$485.32 /30

Type

Active ingredient

NINTEDANIB

NINTEDANIB ESYLATE

Manufacturer

Teva Pharmaceuticals Development Inc

Boehringer Ingelheim

Dosage forms

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Idiopathic Pulmonary Fibrosis

Frequently asked questions

What is the difference between Nintedanib and Ofev?

Nintedanib contains Nintedanib, while Ofev contains Nintedanib Esylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.